Tango Therapeutics IncTNGX
Price$24.45Intrinsic value$10.2858% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $10.28median of 2 methodsbased on filings through 30 Jun 2026
Market Price $24.45Price as of 1 Oct 2026
Margin of Safety -58.0%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: -19.4%/yr (balance of the path).-15.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-14.9%Yr 7-10.4%Yr 8-5.9%Yr 9-1.5%Yr 103.0%
-19.4% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 9.9%
Volatility vs market (adjusted beta)1.10

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTango Therapeutics IncTNGXHealth Care
Valuation
P/E—
P/S73.6×
P/B3.5×
EV / Revenue67.2×
EV / EBITDA-22.4×
Profitability
Gross margin0.0%
Operating margin-253.4%
Net margin-229.9%
FCF margin-268.1%
Returns
ROE-12.1%
ROA-11.5%
ROIC—
Growth
Revenue growth (YoY)27.9%
5-yr fwd EPS growth-28.4%
Financial strength
Debt / Equity0.00×
Current ratio50.82×
Altman Z-Score52.2
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.